Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02074540
Other study ID # HYMC-0005-14
Secondary ID
Status Not yet recruiting
Phase N/A
First received February 26, 2014
Last updated February 26, 2014
Start date April 2014
Est. completion date December 2014

Study information

Verified date February 2014
Source Hillel Yaffe Medical Center
Contact Rinat Majadly, RN, BA
Phone 972-50-9366280
Email noona.412@hotmail.com
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Observational

Clinical Trial Summary

To determine the predicting factors and indicators of compliance with insulin treatment in Diabetes Type II patients.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date December 2014
Est. primary completion date August 2014
Accepts healthy volunteers No
Gender Both
Age group 35 Years to 70 Years
Eligibility Inclusion Criteria:

- With complete cognitive abilities

- Independent functioning

- Take insulin

Exclusion Criteria:

- Critically ill patients

- Psychiatric patients

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
Questionnaire
Questionnaire that is based on socio-demographic characteristics, Morisky's Four-Item Self-Reported Adherence Measure, Becker's Theory of Health Beliefs and Mishel's Theory of Uncertainty

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Hillel Yaffe Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary Insulin adherence Average number of positive responses on the questionnaire scale Forty minutes No
See also
  Status Clinical Trial Phase
Completed NCT01713764 - A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics Phase 2
Completed NCT01121315 - A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary Care N/A
Completed NCT02773095 - Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative N/A
Completed NCT02184455 - Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment Phase 1
Recruiting NCT02361489 - Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices Phase 4
Completed NCT02326129 - Novel Biomarker for Development of T2D